Studies a balloon technique for heart artery blockage in Japanese patients
Observes a balloon treatment for left main heart artery narrowing in adults.
Plain-language title generated from the registry record
Registry title: Japanese Coronary Intervention Using Drug Eluting and Perfusion Therapy for Left Main Disease (JDEPTH-LM Registry)
Key facts
- Where
- Bunkyo, Chiba, Edogawa City, Fuchū, Fukuoka, Gifu, Hakodate, Ichinomiya, Kamakura, Kanazawa, Katsushika-ku, Kitakyushu, Kochi, Kumamoto, Kurashiki, Maebashi, Matsudo, Matsumoto, Matsuyama, Morioka, Sagamihara, Sapporo, Shinagawa, Shinjuku, Toyoake, Tsuchiura, Tsukuba, Urasoe, Urayasu, Wakayama, and Yokosuka, JapanSee the 32 sites
Where in Japan
- The University of Tokyo HospitalBunkyo, JapanNot yet recruiting
- Chiba University HospitalChiba, JapanTaking people
- Moriyama Memorial HospitalEdogawa City, JapanTaking people
- Sakakibara Heart InstituteFuchū, JapanTaking people
- Fukuoka Wajiro HospitalFukuoka, JapanTaking people
- National Hospital Organization Kyushu Medical CenterFukuoka, JapanNot yet recruiting
- Gifu Heart CenterGifu, JapanTaking people
- Hakodate Municipal HospitalHakodate, JapanTaking people
- Ichinomiya Municipal HospitalIchinomiya, JapanTaking people
- Shonan Kamakura General HospitalKamakura, JapanTaking people
- Kanazawa Cardiovascular HospitalKanazawa, JapanTaking people
- Jikei University Katsushika Medical CenterKatsushika-ku, JapanTaking people
- Kokura Memorial HospitalKitakyushu, JapanNot yet recruiting
- Chikamori HospitalKochi, JapanTaking people
- Kumamoto University HospitalKumamoto, JapanTaking people
- Kurashiki Central HospitalKurashiki, JapanNot yet recruiting
- Gunma University HospitalMaebashi, JapanNot yet recruiting
- New Tokyo HospitalMatsudo, JapanTaking people
- Shinshu University HospitalMatsumoto, JapanTaking people
- Ehime Prefectural Central HospitalMatsuyama, JapanTaking people
- Memorial Heart Center Iwate Medical UniversityMorioka, JapanTaking people
- Kitasato University School of MedicineSagamihara, JapanTaking people
- Sapporo Higashi Tokushukai HospitalSapporo, JapanTaking people
- NTT Medical Center TokyoShinagawa, JapanTaking people
- Keio University HospitalShinjuku, JapanNot yet recruiting
- Fujita Health University School of MedicineToyoake, JapanNot yet recruiting
- Tsuchiura Kyodo General HospitalTsuchiura, JapanTaking people
- Tsukuba Medical Center HospitalTsukuba, JapanNot yet recruiting
- Urasoe General HospitalUrasoe, JapanTaking people
- Tokyo Bay Urayasu Ichikawa Medical CenterUrayasu, JapanTaking people
- Japanese Red Cross Wakayama Medical CenterWakayama, JapanTaking people
- Yokosuka Kyosai HospitalYokosuka, JapanTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- TCROSS Co., Ltd.
- Trial code
- NCT06436092
- Record updated
- 13 March 2025
- Original description
JDEPTH-LM Registry is a prospective, observational, multi-center study designed for the efficacy and safety of Double-effect kissing balloon technique (W-KBT) in left main (LM) bifurcation percutaneous coronary intervention (PCI) using Perfusion balloon (PB) and Drug coated balloon (DCB) in patients with left main coronary artery disease (LMD) with left circumflex artery (LCx) ostium stenosis.Read full original descriptionShow less
Japanese Coronary Intervention Using Drug Eluting and Perfusion Therapy for Left Main Disease (JDEPTH-LM Registry)
JDEPTH-LM Registry is a prospective, observational, multi-center study designed for the efficacy and safety of Double-effect kissing balloon technique (W-KBT) in left main (LM) bifurcation percutaneous coronary intervention (PCI) using Perfusion balloon (PB) and Drug coated balloon (DCB) in patients with left main coronary artery disease (LMD) with left circumflex artery (LCx) ostium stenosis.
Inclusion: Age ≥ 18 years; Patient with stable coronary artery disease, non-ST-elevation myocardial infarction, or unstable angina; Left main disease confirmed by coronary angiography or coronary CT angiography; Clinical and anatomical eligibility for PCI as agreed by the local Heart Team; Patient with consent prior to undergoing PCI; Left main Medina classification (1,1,1), (1,0,1), (0,1,1), (0,0,1) confirmed by coronary angiography; De novo target lesion in LMT-LAD amenable for crossover stenting with provisional side-branch approach as determined by PCI operator; De novo ostial LCx lesions; Lesion indicated in No. 8 with a length of less than 10 mm or a stenosis of less than 70% confirmed by coronary angiography.
Exclusion: Patient with a history of ST-elevation myocardial infarction within the previous 1 week; Patient considered unsuitable for anti-thrombotic therapy after PCI; Patient with a history of coronary artery bypass grafting; Patient with malignant tumors or other conditions with a life expectancy of less than one year; Inability to provide written informed consent; Patient in a state of cardiogenic shock; Patient considered suitable for stent placement in the ostial LCx from a medical perspective; Other patient whom the investigator deems unsuitable for the safe conduct of LM-PCI, including W-KBT.